Literature DB >> 10585255

Natural and engineered cytotoxic ribonucleases: therapeutic potential.

S M Rybak1, D L Newton.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10585255     DOI: 10.1006/excr.1999.4718

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


× No keyword cloud information.
  21 in total

1.  Induction of differentiation of leukaemic (HL-60) or prostate cancer (LNCaP, JCA-1) cells potentiates apoptosis triggered by onconase.

Authors:  H D Halicka; T Murakami; C N Papageorgio; A Mittelman; S M Mikulski; K Shogen; Z Darzynkiewicz
Journal:  Cell Prolif       Date:  2000-12       Impact factor: 6.831

Review 2.  Cancer chemotherapy--ribonucleases to the rescue.

Authors:  P A Leland; R T Raines
Journal:  Chem Biol       Date:  2001-05

3.  A novel fully human antitumor immunoRNase resistant to the RNase inhibitor.

Authors:  Gennaro Riccio; Chiara D'Avino; Ronald T Raines; Claudia De Lorenzo
Journal:  Protein Eng Des Sel       Date:  2012-12-11       Impact factor: 1.650

4.  Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation.

Authors:  De Yang; Qian Chen; Helene F Rosenberg; Susanna M Rybak; Dianne L Newton; Zhao Yuan Wang; Qin Fu; Velizar T Tchernev; Minjuan Wang; Barry Schweitzer; Stephen F Kingsmore; Dhavalkumar D Patel; Joost J Oppenheim; O M Zack Howard
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

Review 5.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

Review 6.  Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.

Authors:  W Ardelt; K Shogen; Z Darzynkiewicz
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

7.  Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells.

Authors:  Chiara D'Avino; Rolando Paciello; Gennaro Riccio; Carmela Coppola; Melina Coppola; Paolo Laccetti; Nicola Maurea; Ronald T Raines; Claudia De Lorenzo
Journal:  Protein Eng Des Sel       Date:  2014-01-12       Impact factor: 1.650

8.  Membrane-bound carboxypeptidase E facilitates the entry of eosinophil cationic protein into neuroendocrine cells.

Authors:  Chia-Mao Wu; Hao-Teng Chang; Margaret Dah-Tsyr Chang
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

Review 9.  Ribonucleases as potential modalities in anticancer therapy.

Authors:  Wojciech Ardelt; Barbara Ardelt; Zbigniew Darzynkiewicz
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

10.  Ribonuclease inhibitor as an intracellular sentry.

Authors:  Marcia C Haigis; Erin L Kurten; Ronald T Raines
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.